Display Settings:

Format

Send to:

Choose Destination
Accession: PRJNA290403 ID: 290403

Homo sapiens (human)

Development of colorectal cancer miRNA expression signatures from expression profiles of embryonic development, precancer progression and cancer samples

See Genome Information for Homo sapiens
To further development of our gene expression signature for survival prediction, we conducted expression profiles of embryonic development, precancer progression and cancer samples. More...
AccessionPRJNA290403; GEO: GSE71130
Data TypeTranscriptome or Gene expression
ScopeMultiisolate
OrganismHomo sapiens[Taxonomy ID: 9606]
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo; Homo sapiens
PublicationsAn N et al., "Discovery of a Novel Immune Gene Signature with Profound Prognostic Value in Colorectal Cancer: A Model of Cooperativity Disorientation Created in the Process from Development to Cancer.", PLoS One, 2015;10(9):e0137171
SubmissionRegistration date: 20-Jul-2015
State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, Peking Union Medical College & Cancer Institute (Hospital), Chinese Academy of Medical Sciences
RelevanceMedical
Project Data:
Resource NameNumber
of Links
Publications
PubMed1
PMC1
Other datasets
GEO DataSets1
GEO Data Details
ParameterValue
Data volume, Supplementary Mbytes56

Supplemental Content

Recent activity

  • Homo sapiens
    Homo sapiens
    Development of colorectal cancer miRNA expression signatures from expression profiles of embryonic development, precancer progression and cancer samples
    BioProject
  • feces metagenome
    feces metagenome
    Fecal eukaryotic communites from dung pellets of Tule Elk in California, USA - Elk Dung D0 metagenome
    BioProject
  • Pseudomonas syringae pv. antirrhini str. 126
    Pseudomonas syringae pv. antirrhini str. 126
    Pseudomonas syringae pv. antirrhini str. 126 Genome sequencing
    BioProject
  • The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells th...
    The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
    The PPAR agonist Rosiglitazone induces paracrine signaling in melanoma cells that activate stromal cells and enhances tumor growth.
    BioProject

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center